Summary
ZOE closed today higher at €136.1, an increase of 1.13% from yesterday's close, completing a monthly decrease of -10.35% or €15.72. Over the past 12 months, ZOE stock lost -13.31%.
ZOE pays dividends to its shareholders, with the most recent payment made on Mar 04, 2025. The next announced payment will be in In 1 month on Jun 03, 2025 for a total of €0.5.
The last earnings report, released on Yesterday at 12:00 AM, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 13 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track ZOE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ZOE Chart
Loading, please wait...
Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks | 1 day ago
Zoetis Gears Up to Report Q1 Earnings: Here's What to Expect
ZTS' higher companion animal product sales are likely to have driven revenues in first-quarter 2025 in both the United States and International segments.
Zacks | 2 days ago
1 Superstar Dividend Growth Stock to Buy if the Market Crashes
The stock market has entered a new period of increased uncertainty and volatility following the Trump Administration's desire to reshape America's trade policies. While the market hasn't crashed outright, it has experienced multiple sessions of sharp losses, as well as dramatic rebounds.
Fool | 4 days ago
Zoetis Inc. Dividends
 ZOE 1 weeks ago | Other | €0.44 Per Share |
| ZOE 3 months ago | Other | €0.44 Per Share |
| ZOE 6 months ago | Other | €0.38 Per Share |
| ZOE 9 months ago | Other | €0.38 Per Share |
| ZOE 18 Apr 2024 | Other | €0.38 Per Share |
Zoetis Inc. Earnings
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 11 Feb 2025 Date | | - Cons. EPS | - EPS |
| 4 Nov 2024 Date | | - Cons. EPS | - EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
| 6 Aug 2024 Date | | - Cons. EPS | - EPS |
| ZOE 1 weeks ago | Other | €0.44 Per Share |
| ZOE 3 months ago | Other | €0.44 Per Share |
| ZOE 6 months ago | Other | €0.38 Per Share |
| ZOE 9 months ago | Other | €0.38 Per Share |
| ZOE 18 Apr 2024 | Other | €0.38 Per Share |
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 11 Feb 2025 Date | | - Cons. EPS | - EPS |
| 4 Nov 2024 Date | | - Cons. EPS | - EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
| 6 Aug 2024 Date | | - Cons. EPS | - EPS |
Zoetis Inc. (ZOE) FAQ
What is the stock price today?
The current price is €136.10.
On which exchange is it traded?
Zoetis Inc. is listed on NYSE.
What is its stock symbol?
The ticker symbol is ZOE.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Zoetis Inc. ever had a stock split?
No, there has never been a stock split.
Zoetis Inc. Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Ms. Kristin C. Peck CEO | XMUN Exchange | US98978V1035 ISIN |
| US Country | 14,100 Employees | 21 Apr 2025 Last Dividend | - Last Split | 1 Feb 2013 IPO Date |
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
Contact Information
Address: 10 Sylvan Way, Parsippany, NJ, United States, 07054
Phone: 973 822 7000
Website: https://www.zoetis.com
2025 © Marketlog. All Rights Reserved.
